A detailed investigation and understanding of the mutual regulation of the Hippo and TGFβ signaling pathways might allow us to propose new therapeutic approaches for the treatment of idiopathic pulmonary fibrosis (Fig. 3). This evidence concerns the gene TGFB1 and pulmonary fibrosis.